期刊
GUT MICROBES
卷 14, 期 1, 页码 -出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/19490976.2022.2046246
关键词
Colorectal cancer; immunotherapy; anti-PD-1; gut microbiota; probiotics; tumor microenvironment
资金
- National Natural Science Foundation of China [81872245, 81803601]
- Shanghai Sailing Program [17YF1416700]
The gut microbiota plays a critical role in cancer immunotherapy outcomes. The study found that the gut microbiota from healthy individuals enhances sensitivity to anti-PD-1 in colorectal cancer tumor-bearing mice, while gut microbiota from CRC patients does not have the same effect. Lactobacillus was identified as a key species significantly increased in mice with a good response to anti-PD-1, and it was correlated with anti-tumor immunity. The novel strain L. paracasei sh2020 demonstrated notable anti-tumor immunity and enhanced gut barrier function, suggesting its potential as an effective way to promote the effect of anti-PD-1 in clinical practice.
The gut microbiota was emerging as critical regulatory elements in shaping the outcome of cancer immunotherapy. However, the underlying mechanisms by which the gut commensal species enhance antitumor immunity remain largely unexplored. Here, we show that the gut microbiota from healthy individuals conferred considerable sensitivity to anti-PD-1 in the colorectal cancer (CRC) tumor-bearing mice, whereas gut microbiota from CRC patients failed to do so. By 16S rRNA gene sequencing, we identified Lactobacillus that was significantly increased in the mice with good response to anti-PD-1, and significantly correlated with anti-tumor immunity. After a series of screening, we isolated a novel Lacticaseibacillus strain, named L. paracasei sh2020. L. paracasei sh2020 showed the most notable anti-tumor immunity in the mice with gut dysbiosis. Mechanistically, the antitumor immune response elicited by L. paracasei sh2020 was dependent on CD8(+) T cell. In vitro and in vivo studies revealed that L. paracasei sh2020 stimulation triggered the upregulated expression of CXCL10 in the tumors and subsequently enhanced CD8(+) T cell recruitment. Meanwhile, the modulation of gut microbiota caused by L. paracasei sh2020 enhanced its antitumor effect and gut barrier function. Overall, our study offered novel insights into the mechanism by which gut microbiota shaped the outcome of cancer immunotherapy and, more importantly, the novel strain L. paracasei sh2020 might serve as an easy and effective way to promote anti-PD-1 effect in clinical practice.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据